Tomoki Todo

9.7k citations

143 papers · 7.2k indexed · 4 hit papers · h-index 43

Impact in

Genetics top 0.2%
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
Oncology top 0.5%
- CAR-T cell therapy research

Papers in ⓘ

Genetics 25
- Virus-based gene therapy research 62
- Glioma Diagnosis and Treatment 23
Oncology 43
- CAR-T cell therapy research 32

Co-authors: Yasushi Ino (42 shared papers)Samuel D. Rabkin (16 shared papers)Hiroshi Fukuhara (20 shared papers)Robert L. Martuza (13 shared papers)Minoru Tanaka (11 shared papers)Paul A. Johnson (2 shared papers)Kohei Miyazono (8 shared papers)Frank Feigenbaum (3 shared papers)
Journals: Neurosurgery (13 papers)Molecular Therapy — Oncolytics (9 papers)Journal of neurosurgery (9 papers)Cancer Science (8 papers)Molecular Therapy (8 papers)
Partner nations: Japan United States Germany

In The Last Decade

Tomoki Todo

141 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial 2022 · 317 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Medicine
2022 Nature Communications
2016 Cancer Science
2000 Gene Therapy

Peers

Countries citing papers authored by Tomoki Todo

Since Specialization

Citations

This map shows the geographic impact of Tomoki Todo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Todo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Todo more than expected).

Fields of papers citing papers by Tomoki Todo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Todo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Todo. The network helps show where Tomoki Todo may publish in the future.

Co-authors

The 25 scholars most cited alongside Tomoki Todo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tomoki Todo Line = papers co-authored together Tomoki Todo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial Gene Therapy ·James M. Markert, Michael D. Medlock, Samuel D. Rabkin, G. Yancey Gillespie, Tomoki Todo, William D. Hunter, Cheryl A. Palmer, Frank Feigenbaum, Carlo Tornatore, Frank Tufaro, R L Martuza Hit paper breakdown →	2000	794
2	Oncolytic virus therapy: A new era of cancer treatment at dawn Cancer Science ·Hiroshi Fukuhara, Yasushi Ino, Tomoki Todo Hit paper breakdown →	2016	564
3	Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors Cell stem cell ·Hiroaki Ikushima, Tomoki Todo, Yasushi Ino, Masamichi Takahashi, Keiji Miyazawa, Kohei Miyazono	2009	438
4	Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing Proceedings of the National Academy of Sciences ·Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin, Paul A. Johnson	2001	373
5	Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial Nature Medicine ·Tomoki Todo, Hirotaka Ito, Yasushi Ino, Hiroshi Ohtsu, Yasunori Ota, Junji Shibahara, Minoru Tanaka Hit paper breakdown →	2022	317
6	Systemic Antitumor Immunity in Experimental Brain Tumor Therapy Using a Multimutated, Replication-Competent Herpes Simplex Virus Human Gene Therapy ·Tomoki Todo, Samuel D. Rabkin, Periasamy Sundaresan, Aiguo Wu, Kenneth R. Meehan, Herbert B. Herscowitz, Robert L. Martuza	1999	172
7	Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman Primates Journal of Virology ·William D. Hunter, Robert L. Martuza, Frank Feigenbaum, Tomoki Todo, Toshihiro Mineta, Takahito Yazaki, Masahiro Toda, Joseph T. Newsome, R. Craig Platenberg, Herbert J. Manz, Samuel D. Rabkin	1999	158
8	Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation Journal of neurosurgery ·Kyousuke Kamada, Tomoki Todo, Yoshitaka Masutani, Shigeki Aoki, Kenji Ino, Tetsuya Takano, Takaaki Kirino, Nobutaka Kawahara, Akio Morita	2005	149
9	Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase Journal of neurosurgery ·Tomoki Todo, Masaaki Usui, Kintomo Takakura	1991	145
10	A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma Nature Communications ·Tomoki Todo, Yasushi Ino, Hiroshi Ohtsu, Junji Shibahara, Minoru Tanaka Hit paper breakdown →	2022	135
11	Cloning and characterization of a gene (UVR3) required for photorepair of 6-4 photoproducts in Arabidopsis thaliana Nucleic Acids Research ·Satoshi Nakajima, Munetaka Sugiyama, Shigenori Iwai, Kenichi Hitomi, Eriko Otoshi, Sang‐Tae Kim, Cai‐Zhong Jiang, Tomoki Todo, Anne Britt, Kazuo Yamamoto	1998	124
12	Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein Journal of Biological Chemistry ·Hiroaki Ikushima, Tomoki Todo, Yasushi Ino, Masamichi Takahashi, Nobuhito Saito, Keiji Miyazawa, Kohei Miyazono	2011	121
13	The motor-evoked potential threshold evaluated by tractography and electrical stimulation Journal of neurosurgery ·Kyousuke Kamada, Tomoki Todo, Takahiro Ota, Kenji Ino, Yoshitaka Masutani, Shigeki Aoki, Fumiya Takeuchi, Kensuke Kawai, Nobuhito Saito	2009	109
14	5-Hydroxymethylcytosine Plays a Critical Role in Glioblastomagenesis by Recruiting the CHTOP-Methylosome Complex Cell Reports ·Hiroki Takai, Koji Masuda, Tomohiro Sato, Yuriko Sakaguchi, Takeo Suzuki, Tsutomu Suzuki, Ryo Koyama‐Nasu, Yukiko Nasu‐Nishimura, Yuki Katou, Haruo Ogawa, Yasuyuki Morishita, Hiroko Kozuka‐Hata, Masaaki Oyama, Tomoki Todo, Yasushi Ino, Akitake Mukasa, Nobuhito Saito, Chikashi Toyoshima, Katsuhiko Shirahige, Tetsu Akiyama	2014	108
15	Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma Neoplasia ·Ali Chahlavi, Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin	1999	99
16	Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice Gene Therapy ·Ali Chahlavi, Samuel D. Rabkin, Tomoki Todo, Periasamy Sundaresan, R L Martuza	1999	85
17	Triple Combination of Oncolytic Herpes Simplex Virus-1 Vectors Armed with Interleukin-12, Interleukin-18, or Soluble B7-1 Results in Enhanced Antitumor Efficacy Clinical Cancer Research ·Yasushi Ino, Yoshinaga Saeki, Hiroshi Fukuhara, Tomoki Todo	2006	83
18	Functional Monitoring for Visual Pathway Using Real-time Visual Evoked Potentials and Optic-radiation Tractography Operative Neurosurgery ·Kyousuke Kamada, Tomoki Todo, Akio Morita, Yoshitaka Masutani, Shigeki Aoki, Kenji Ino, Kensuke Kawai, Takaaki Kirino	2005	80
19	Triple Gene-Deleted Oncolytic Herpes Simplex Virus Vector Double-Armed with Interleukin 18 and Soluble B7-1 Constructed by Bacterial Artificial Chromosome–Mediated System Cancer Research ·Hiroshi Fukuhara, Yasushi Ino, Toshihiko Kuroda, Robert L. Martuza, Tomoki Todo	2005	76
20	Viral Shedding and Biodistribution of G207, a MuItimutated, Conditionally Replicating Herpes Simplex Virus Type 1, after Intracerebral Inoculation in Aotus Molecular Therapy ·Tomoki Todo, Frank Feigenbaum, Samuel D. Rabkin, Fred D. Lakeman, Joseph T. Newsome, Paul A. Johnson, Erin Mitchell, Daniel J. Belliveau, Jeffrey M. Ostrove, Robert L. Martuza	2000	76

About Tomoki Todo

Tomoki Todo is a scholar working on Genetics, Genetics, Oncology, Epidemiology and Biotechnology, having authored 143 papers that have together received 7.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (62 papers), Herpesvirus Infections and Treatments (40 papers), CAR-T cell therapy research (32 papers), Glioma Diagnosis and Treatment (23 papers), Viral Infectious Diseases and Gene Expression in Insects (23 papers), Cancer Research and Treatments (12 papers), RNA Interference and Gene Delivery (10 papers) and Meningioma and schwannoma management (7 papers). The work is most often cited by research in Genetics (3.4k citations), Oncology (2.8k citations), Genetics (973 citations), Biotechnology (518 citations) and Epidemiology (1.8k citations). Tomoki Todo has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yasushi Ino, Samuel D. Rabkin, Hiroshi Fukuhara, Robert L. Martuza, Minoru Tanaka, Paul A. Johnson, Kohei Miyazono, Frank Feigenbaum, Nobuhito Saito and Keiji Miyazawa. Their work appears in journals such as Neurosurgery, Molecular Therapy — Oncolytics, Journal of neurosurgery, Cancer Science and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact